Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03097627 · ClinicalTrials.gov registry record · Phase 1
Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions
A Phase 1 study of Pulmonary Nodule, Solitary and Pulmonary Nodule, Multiple, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT03097627 is a Phase 1 study of Pulmonary Nodule, Solitary and Pulmonary Nodule, Multiple that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03097627, a Phase 1 study of Pulmonary Nodule, Solitary and Pulmonary Nodule, Multiple, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical trial to evaluate the intravenous administration of indocyanine green (ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine if intravenous ICG allows us to identify intra-thoracic lesions.
Conditions Studied
Interventions
- DRUG ICG Intervention
- DEVICE Near Infrared Camera
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-02-01 |
| Est. Completion | 2016-10-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03097627
The ClinicalTrials.gov registry entry for NCT03097627 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Nodule, Solitary appearing as the primary indexed condition, and to 2 interventions - of which ICG Intervention is the first listed.
NCT03097627 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03097627 about?
NCT03097627 is a clinical study titled "Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions". This is a clinical trial to evaluate the intravenous administration of indocyanine green (ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine if intravenous ICG allows us to identify intra-thoracic lesions.
What is the current status of trial NCT03097627?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2016-02-01. Estimated completion is 2016-10-28.
What conditions does trial NCT03097627 study?
This clinical trial studies the following conditions: Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple.
What interventions are being tested in trial NCT03097627?
The interventions under investigation include: ICG Intervention (DRUG), Near Infrared Camera (DEVICE).
Who is sponsoring clinical trial NCT03097627?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03097627 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Nodule, Solitary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Pulmonary Nodule, Solitary
All registered trials for this condition
Pulmonary Nodule, Multiple
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.